United Patients Group

JUNE 8, 2023

A high-quality patient experience is paramount in any healthcare setting. Satisfied patients are more likely to trust their healthcare providers. It encourages patients to ask questions, provide accurate information, and participate in shared decision-making, leading to better treatment adherence and overall care quality.

Patients 52

Patients Data Collective Environment 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

AUGUST 2, 2021

The lab was born to fulfill an unmatched need in the industry to deliver a reliable, scientifically based standard methodology to allow patients to control their individual dose and overall predictability of a product’s intended therapeutic effects. “We Media Contact: Shawna Hassett, shassett@duffyshanley.com.

Hemp 105

Hemp Data Cultivation Patients 105

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Veriheal

APRIL 23, 2024

Understanding Gen Z Gen Z has been spotlighted in the media recently for a variety of reasons, one of which is that they are the largest consumers of media across any generation. By knowing what Gen Z values about cannabis, we can better provide for upcoming generations to ensure everyone is having their needs met.

Chronic Pain 111

Chronic Pain Data Edibles Sleep 111

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JANUARY 3, 2022

According to the amendment to the law on addictive substances and drugs, which came into force on January 1, doctors will now only prescribe medical marijuana to their patients electronically. Almost 200 doctors throughout the Czech Republic are currently prescribing therapeutic cannabis to some of their patients. Source: CTK.

Media 52

Media Chronic Pain Patients Treatment 52

Cannabis Law Report

AUGUST 27, 2021

The Board will further serve as a resource for media, other medical associates and general audiences interested in the science behind psychedelic wellness and treatments. Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Research and Development 98

Research and Development Treatment Media Medicine 98

LifeCannMD

JANUARY 2, 2025

Believe it or not, many cancer patients in Miami have been clearing the shelves to not only relieve cancer pain , but also for the hope that RSO can help them with the cancer itself. This hope comes from many individuals posting their stories (true or not) on social media. What Makes RSO Special?

Oil 98

Oil Concentrates Treatment Chronic Pain 98

Illinois News Joint

DECEMBER 18, 2023

From medical patients to MSOs, News Joint Consulting connects clients to cannabis insiders across the industry, including academics, municipalities, politicians, associations, event planners, conference organizers, vendors, new business owners, cultivators, breeders, brands, influencers, and more.

Events 105

Events Media Patients Data 105

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. COMP360 psilocybin therapy has now been given to 233 patients, exceeding 216 target. On track to report top-line data by end of 2021. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. Ehave, Inc. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

OCTOBER 26, 2019

What with share prices tumbling in the US & Canada we notice cannabis media are sloshing around looking for the next good news story and this past week Germany appears to be in vogue. MJ Biz run the “New data reveals top medical conditions for which cannabis is reimbursed in Germany” story. A Growing Market.

Media 45

Media Policy Data Conditions 45

SpeedWeed

JUNE 2, 2021

Data from Marijuana Business Daily’s 2021 Annual Marijuana Business Factbook puts the growth potential of the cannabis industry over the next several years into perspective. According to the data in the 2021 Annual Marijuana Business Factbook , U.S. Cannabis Sales Growth. cannabis sales will climb to $48.4 View original article.

Data 40

Data Media Business Cannabis 40

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

JULY 9, 2021

The medical use of certain psychedelic drugs and substances remain illegal under Canadian federal law unless discretionary exemptions are granted under the CDSA, while a limited number of other drugs and substances may be prescribed by a health care practitioner to patients under their care. SOURCE Horizons ETFs Management ( Canada ) Inc.

Data 105

Data Clinical Trials Decriminalization Hemp 105

Cannabis Law Report

SEPTEMBER 15, 2019

The full media report dated 30 August 2019 can be found at. According to a media report , the German government took almost 13.3 These data are based on an extrapolation of the top pharmacist association. At the end of 2020, cannabis from German cultivation should be available for patients. ( Leafly.de reported. ).

Media 45

Media Medicine Collective Data 45

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. There’s another problem: science communication and literacy.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.fda.gov/media/131878/download. Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” Specifically, the agency fears that.

CBD 103

CBD Safety Topical Food 103

Cannabis Law Report

JULY 22, 2021

. “By acquiring traditional healthcare assets and subsequently layering in alternative medicines and psychedelic therapies as regulations develop, Levitee will have direct and immediate access to a much broader patient population. Levitee Media Contact. media@leviteelabs.com. The CSE (operated by CNSX Markets Inc.)

eCommerce 105

eCommerce Therapy Media Access 105

SpeedWeed

MARCH 17, 2021

Deal size aside, we wanted to share what we look at on the data side when a public company or MSO announces a deal. Today, Curaleaf LLC is one of four licensed growers in Connecticut and operates a 60,000 square foot cultivation facility in Simsbury that provides cannabis products to over 40,000 patients throughout the state.

Media 52

Media Data Dispensary Cultivation 52

SpeedWeed

JULY 25, 2021

Here are the applicants and their scores with notable MSO losses in red text: Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media.

Media 52

Media Data Dispensary Access 52

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Illinois News Joint

MAY 27, 2023

With the immense popularity of Kaviar spawning in such a short time, the team invested heavily in marketing at industry events, interacting with customers directly at dispensaries, and cultivating an engaging following on social media. To qualify and receive a medical patient card at a discounted rate, visit here.

Terpenes 98

Terpenes Strains Dispensary Events 98

Cannabis Law Report

JULY 29, 2021

There have been various individual studies of the condition, but the Ehave study could be the largest patient study to date. EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Media Inquiries: Gabe Rodriguez. Forward-Looking Statement Disclaimer. Contact: Ehave Inc.

Research and Development 81

Research and Development Conditions Data Patients 81

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.

Data 60

Data Policy Media Cannabis 60

SpeedWeed

MARCH 9, 2021

Despite surging sales and patient numbers, Oklahoma ended 2020 with 181 fewer retail licenses than it did in 2019 – even after issuing 565 new permits throughout 2020, according to Cannabiz Media, a Connecticut-based cannabis license database and marketing platform. The entire U.S. licenses per 1,000 people.

Dispensary 52

Dispensary Seed-To-Sale Media Retail 52

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE. ” About COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

JUNE 30, 2021

Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. of patients with major depressive disorder, 92.7% of patients with bipolar disorder, 71% of patients with generalized anxiety disorder, and 97.8% of patients with social anxiety disorder. Building the Data Backend.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

NOVEMBER 22, 2019

“Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. MMJ is confident that their pharmaceutical drugs will bring much needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington’s Disease. For media inquiries please contact: Michael Sharp.

DEA 51

DEA Clinical Trials THC Research and Development 51

Cannabis Law Report

JULY 9, 2021

We are excited to begin cultivation in West Virginia and be one step closer to providing relief to the patients who need it,” said Nicholas Vita, CEO of Columbia Care. Media Contacts Lindsay Wilson. media@col-care.com. Our ability to begin operations solidifies our position as a leader in the state. About Columbia Care.

Research and Development 81

Research and Development Cultivation Seed-To-Sale Dispensary 81

Cannabis Law Report

AUGUST 9, 2021

With this agreement, , we will have the opportunity to shape the Israeli CBD market and leverage IMC’s new and expanding retail presence, distribution capabilities and data-driven insights to reach our patients and future consumers with a leading brand such as cbdMD,” said Oren Shuster, IMC’s CEO. “We About cbdMD, Inc. cbdMD, Inc.

Seed-To-Sale 81

Seed-To-Sale CBD Tincture Retail 81

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Epilepsy Cannabinoids THC 74

The Blunt Truth

AUGUST 13, 2019

To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps. In its most recent warning letter, dated July 22, 2019, the FDA asserted that Curaleaf Inc.,

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

SEPTEMBER 20, 2021

KWC and KIC have been focused on opening locations in Secondary cities with considerable demand, in an effort to provide access to the most patients. Adding KWC will ensure our existing patients and many more in the future will receive the best medical treatment and care.

Treatment 52

Treatment Media Research and Development Patients 52